Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations Carolina Delgado Martínez; Mariano Gómez-Rubio; Cecilia Gómez-Domínguez;

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;

HLA-G liver expression in chronically HIV/hepatitis C-coinfected individuals. Fernando Crivelenti Vilar; Eduardo Donadi; Benedito Antônio Lopes da Fonseca; Janaina Cristiana de Oliveira Crispim Freitas; Ana Letícia Gomide Zanin Borducchi; Rodrigo de Carvalho Santana;